INBX
Inhibrx, Inc. Common Stock
INBX
INBX
Delisted
INBX was delisted on the 29th of May, 2024.
102 hedge funds and large institutions have $512M invested in Inhibrx, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
97% less call options, than puts
Call options by funds: $369K | Put options by funds: $12.7M
Holders
102
Holding in Top 10
1
Calls
$369K
Puts
$12.7M
Top Buyers
| 1 | +$27.1M | |
| 2 | +$17.5M | |
| 3 | +$10.6M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.53M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.65M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$8.09M | |
| 3 | -$5.34M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.34M |
| 5 |
SCM
Sio Capital Management
New York
|
-$4.14M |